Calliditas Therapeutics AB (publ) (CALT)

CALT Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	973.73	973.73	1,249	955.51	996.3	753.54
Cash & Cash Equivalents	973.73	973.73	1,249	955.51	996.3	753.54
Cash Growth	17.97%	-22.04%	30.73%	-4.09%	32.22%	16.62%
Receivables	180.89	180.89	78.7	0	0	46.59
Inventory	20.43	20.43	3.65	0.89	0	0
Other Current Assets	100.1	100.1	80.76	56.38	40.55	21.01
Total Current Assets	1,275	1,275	1,412	1,013	1,037	821.13
Property, Plant & Equipment	54.24	54.24	31.92	39.61	5.41	6.06
Long-Term Investments	24.2	24.2	11.21	3.92	2.23	1.94
Goodwill and Intangibles	479.34	479.34	483.84	399.42	418.83	16.07
Other Long-Term Assets	26.32	26.32	13.8	4.2	0.6	0
Total Long-Term Assets	584.09	584.09	540.77	447.14	427.06	24.07
Total Assets	1,859	1,859	1,953	1,460	1,464	845.2
Accounts Payable	100.56	100.56	160.4	67.97	53.83	24.38
Other Current Liabilities	306.58	306.58	164.83	67.48	51.79	28.99
Total Current Liabilities	407.14	407.14	325.23	135.45	105.62	53.37
Long-Term Debt	966.6	966.6	728.82	213.22	0.88	0
Other Long-Term Liabilities	150.7	150.7	132.66	102.97	101.11	3.76
Total Long-Term Liabilities	1,117	1,117	861.48	316.18	101.99	3.76
Total Liabilities	1,524	1,524	1,187	451.63	207.61	57.13
Total Debt	966.6	966.6	728.82	213.22	0.88	0
Debt Growth	350.65%	32.62%	241.82%	24184.28%	-	-
Retained Earnings	-2,305.57	-2,305.57	-1,836.32	-1,426.57	-918.6	-488.1
Shareholders' Equity	334.81	334.81	766.26	1,008	1,210	788.07
Net Cash / Debt	7.14	7.14	520.27	742.29	995.43	753.54
Net Cash / Debt Growth	-98.83%	-98.63%	-29.91%	-25.43%	32.10%	16.62%
Working Capital	868.01	868.01	1,087	877.33	931.23	767.76
Book Value Per Share	11.24	11.24	25.93	40.38	52.29	34.05

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).